Latest news
Loading news…
Synkrino Biotherapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Berkeley, California, United States Founded 2018 1-10 employees For Profit
Synkrino Biotherapeutics is a biotech platform that discovers and develops novel drug targets directly from the immune system of patients.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 8
Company Info
- Founded
- 2018
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 3
- HQ
- Berkeley, California, United States
- Region
- San Francisco Bay Area, West Coast, Western US
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 2.2
- Trend (30d)
- -0.1
- Trend (90d)
- -0.3
Key People at Synkrino Biotherapeutics
Co-Founder and CEO
CTO and Co-Founder
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Synkrino Biotherapeutics
Loading news…
FAQs about Synkrino Biotherapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.